Option Bears Feel the Sting of Bristol-Myers Squibb Company (BMY) Rally

Short-term Bristol-Myers Squibb Co (BMY) traders have rarely been as put-heavy as they are now

by Karee Venema

Published on Jan 12, 2015 at 11:06 AM
Updated on Apr 20, 2015 at 5:32 PM

Bristol-Myers Squibb Co (NYSE:BMY) is up 4.4% at $62.98 -- and earlier tagged a fresh 14-year peak of $64.44 -- on news the company's lung cancer drug, Opdivo, met the endpoint goals of its late-stage trial. Today's price action is being met with a rush of call activity in the equity's options pits, with the contracts trading at nearly six times the average intraday pace -- a scenario that runs counter to the withstanding trend.

Specifically, the equity's 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) put/call volume ratio of 0.60 ranks in the bearishly skewed 67th annual percentile. Even more telling is BMY's Schaeffer's put/call open interest ratio (SOIR) of 1.21, which ranks just 4 percentage points from a 52-week peak. Simply stated, short-term speculators have rarely been as put-skewed toward BMY as they are now.

Technically speaking, BMY has been in rally mode since hitting its most recent low of $47.54 in mid-October, with the shares up more than 32%. Therefore, it's entirely possible that a portion of the recent put buying is a result of shareholders protecting their paper profits against a pullback. Regardless, the equity's near-term options are currently pricing in lofty volatility expectations, per BMY's Schaeffer's Volatility Index (SVI) of 38%, which ranks higher than all similar readings taken in the past year.

Should Bristol-Myers Squibb Co (NYSE:BMY) extend its positive momentum, a round of upgrades and/or price-target hikes could help fuel the stock's fire. At present, 47% of covering analysts maintain a "hold" or "strong sell" suggestion, while the average 12-month price target of $57.21 stands at a discount to current trading levels.


A Schaeffer's exclusive

TOP STOCK PICKS 2020

Access your FREE insider report before it's too late!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


IRA/401k: The Crash-Proof Retirement Plan
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.
Stocks Eye Notable Weekly Gains on 3-Day Surge
Stocks are eyeing big weekly gains
WW Stock Brushes Off Bull Note
Morgan Stanley upgraded the Weight Watchers parent to "overweight" from "equal weight"
IRA/401k: The Crash-Proof Retirement Plan
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.